Reducing Pain Associated with Intravenous Cannulation in School Age Childre
- Conditions
- Pain management related intravenous cannulation.
- Registration Number
- IRCT20230714058776N1
- Lead Sponsor
- College of Nursing, University of Baghdad
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete
- Sex
- All
- Target Recruitment
- 128
Consent to volunteer to participate in the study.
Being between the ages of 6 and 12 years.
Intravenous cannulation will be applied in right and left hand only.
No difficulty in communication, including hearing, visual, speech, and language problems.
Not receiving oral or parenteral analgesic treatment before administration.
Not receiving chemotherapy treatment.
Skin conditions such as burns, rashes, open wounds, abscess or boil, severe local infection or cellulitis at the intended insertion site.
Peripheral vascular disease or compromised peripheral circulation at the intended insertion site (e. g. Peripheral neuropathy, diabetes, Peripheral artery disease, Raynaud's disease).
Blood clotting disorders or increased risk of bleeding (e.g., hemophilia, thrombocytopenia).
Anatomical abnormalities or restrictions that impede proper insertion or cause increased risk of complications.
History of injections during the last 3 months.
Study & Design
- Study Type
- interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Intravenous cannulation related pain (reducing). Timepoint: The patient's response after giving the intravenous cannulation directly to measure the intensity of pain. Method of measurement: Pain scale (Wong-Baker Faces) to measure the intensity of pain as a result of intravenous cannulation.
- Secondary Outcome Measures
Name Time Method